Renaissance Technologies (RenTech)'s SLN Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 16,930 shares of Silence Therapeutics plc (SLN) worth $185,891, representing 0.00% of the portfolio. First purchased in 2023-Q4, this short-term holding has been held for 5 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in SLN for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2024, adding 76,798 shares. Largest reduction occurred in Q2 2024, reducing 64,800 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Silence Therapeutics plc (SLN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Silence Therapeutics plc (SLN) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +16,930 | New Buy | 16,930 | $10.98 |
| Q3 2024 | -39,100 | Sold Out | 0 | $0.00 |
| Q2 2024 | -64,800 | Reduce 62.37% | 39,100 | $19.00 |
| Q1 2024 | +76,798 | Add 283.37% | 103,900 | $21.60 |
| Q4 2023 | +27,102 | New Buy | 27,102 | $17.38 |
Renaissance Technologies (RenTech)'s Silence Therapeutics plc Investment FAQs
Renaissance Technologies (RenTech) first purchased Silence Therapeutics plc (SLN) in Q4 2023, acquiring 27,102 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Silence Therapeutics plc (SLN) for 5 quarters since Q4 2023.
Renaissance Technologies (RenTech)'s largest addition to Silence Therapeutics plc (SLN) was in Q1 2024, adding 103,900 shares worth $2.24 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 16,930 shares of Silence Therapeutics plc (SLN), valued at approximately $185,891.
As of the Q2 2026 filing, Silence Therapeutics plc (SLN) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Silence Therapeutics plc (SLN) was 103,900 shares, as reported at the end of Q1 2024.